Skip to content

Healthcare study to improve the vaccination status of patients after liver transplantation

Healthcare study to improve the vaccination status of patients after liver transplantation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00035422
Enrollment
401
Registered
2024-11-04
Start date
2016-12-15
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Need for vaccination in immunocompromised individuals due to liver transplantation

Interventions

Group 1: patient intervention: yellow information letter emphasizing the importance of a complete vaccination status. The personalized letter was sent to patients once in December 2016. Group 2: famil

Sponsors

Medizinische Fakultät, Universität Duisburg-Essen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Liver transplantation

Exclusion criteria

Exclusion criteria: Lack of German language skills; transplant <6 months.

Design outcomes

Primary

MeasureTime frame
Proportion of fully vaccinated patients in relation to each individual standard and indication vaccination and in relation to a complete vaccination status for all indicated standard and indication vaccinations in liver transplant patients at baseline ((15.12.2016) and follow-up (31.12.2018). Using the patients' vaccination records, the prevalence rates for each vaccination are quantified for 2016 (cut-off date up to December 31, 2016) and 2018 (cut-off date up to December 31, 2018).

Secondary

MeasureTime frame
Proportion of fully vaccinated patients in relation to each individual standard and indication vaccination and in relation to a complete vaccination status for all indicated standard and indication vaccinations in liver transplant patients depending on the intervention group at the baseline and follow-up time points. Using the patients' vaccination records, the prevalence rates for each vaccination are quantified for all three groups for 2016 (cut-off date up to December 31, 2016) and 2018 (cut-off date up to December 31, 2018).

Countries

Germany

Contacts

Public ContactDorothea Dehnen

Medizinische Fakultät, Universität Duisburg-Essen, Institut für Allgemeinmedizin

dorothea.dehnen@uk-essen.de+492017238036

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026